6185 — Cansino Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.39bn
- HK$2.87bn
- CNY345.18m
Annual cashflow statement for Cansino Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -157 | -407 | 1,907 | -1,184 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -26.6 | -23.7 | -135 | 545 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.29 | -70.4 | 154 | -1,445 | -916 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -170 | -469 | 2,015 | -1,888 | -916 |
| Capital Expenditures | -117 | -271 | -1,203 | -1,075 | -610 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -681 | 88.1 | -1,328 | -117 | 169 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -798 | -183 | -2,531 | -1,192 | -442 |
| Financing Cash Flow Items | -29.6 | -20.2 | 591 | -47.4 | -53.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,091 | 4,924 | 1,560 | 855 | -7.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 145 | 4,244 | 1,009 | -2,064 | -1,345 |